Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2022-07-08 00:00:00 ET · period of report 2022-07-07 · accession 0001415889-22-007606 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-08 | 2022-07-08 | UTHR | KURZWEIL RAY | Dir | M - OptEx | $0.00 | +3,230 | 12.4K | +35% | $0 |
| DM | 2022-07-08 | 2022-07-07 | UTHR | KURZWEIL RAY | Dir | A - Grant | $0.00 | +3,370 | 2,490 | New | $0 |
| D | 2022-07-08 | 2022-07-08 | UTHR | KURZWEIL RAY | Dir | M - OptEx | $0.00 | -3,230 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-08 | M | A | 3,230 | $0.00 | 12,450 | D | — | — | (F1) Shares received upon vesting of restricted stock units on July 8, 2022. Restricted stock units converted on a one-for-one basis into shares of common stock. |
| 2 | Derivative | Restricted Stock Unit | 2022-07-07 | A | A | 880 | $0.00 | 880 | D | $0.00 · 2023-07-07 to — | 880 Common Stock | (F4) Annual non-employee director award. (F2) Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. (F3) Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. |
| 3 | Derivative | Stock Options | 2022-07-07 | A | A | 2,490 | $0.00 | 2,490 | D | $240.20 · 2023-07-07 to 2032-07-07 | 2,490 Common Stock | (F4) Annual non-employee director award. (F3) Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. |
| 4 | Derivative | Restricted Stock Unit | 2022-07-08 | M | D | 3,230 | $0.00 | 0 | D | $0.00 · 2022-07-08 to — | 3,230 Common Stock | (F2) Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. (F3) Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. |